According to a new study published in the journal Cell, scientists from the Harvard Medical School, the University of Montreal and the Dana-Farber Cancer Institute have found a new way by which nerve cells relay information that tell them to grow from millimeters to meters in length. In other words, the researchers found a new signaling pathway that charters the course for cell progression to allow their growth. The team made an intriguing connection between nerve cells and a receptor called DCC (Deleted in Colorectal Carcinoma). The discovery means cells perform functions in unimagined ways – challenging previous views on how cells respond to their environment – that could prove beneficial in cell growth following nerve damage or detrimental in diseases such as cancer.
“We found an alternate way that helps nerve cells respond quickly and locally,” says co-author Philippe P. Roux, a professor of pathology and cell biology and a researcher at the University of Montreal Institute for Research in Immunology and Cancer (IRIC). “This is just the beginning, since our findings suggest that more cellular receptors may function in the same way.”
Dr. Roux, who is also Canada Research Chair in Signal Transduction and Proteomics, says the study could potentially open new treatment avenues: “We can envisage manipulating this alternate mechanism to make cells respond locally to their environment. Our findings mean that scientists must consider a new way that cells organize themselves to perform essential functions.”
Partners in research: About the study:
This study was supported by the National Institutes of Health, Canadian Cancer Society Research Institute, Howard Hughes Medical Institute, Canadian Institutes of Health Research and Human Frontier Science Program Organization.
The article, “Transmembrane Receptor DCC Associates with Protein Synthesis Machinery and Regulates Translation,” published in the journal Cell, was authored by Joseph Tcherkezian, Perry A. Brittis and John G. Flanagan of the Harvard Medical School; Franziska Thomas of the Dana-Farber Cancer Institute; Philippe P. Roux of the University of Montreal.
About the study:
Note to editors:
The Université de Montréal name can be adapted to University of Montreal (never Montreal University).
On the Web:
- Université de Montréal
- Department of Pathology and Cell Biology
- Institute for Research in Immunology and Cancer
- Harvard Medical School
- Dana-Farber Cancer Institute
International press attaché
Université de Montréal